Patients in the taper group had fewer maximum consecutive weeks of opioid abstinence compared with those in the maintenance group ( mean abstinence , 2.70 [ 95 % CI , 1.72-3 .75 ] vs 5.20 [ 95 % CI , 4.16-6 .20 ] weeks ) .